4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.

Zheng, Zongyu

4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement. [electronic resource] - Journal of cellular and molecular medicine 08 2019 - 5771-5781 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1582-4934

10.1111/jcmm.14493 doi


AMP-Activated Protein Kinases--metabolism
Animals
Biphenyl Compounds--pharmacology
Blood Glucose--metabolism
Diabetes Mellitus, Experimental--blood
Diabetes Mellitus, Type 2--blood
Diabetic Cardiomyopathies--complications
Fibrosis
Inflammation--blood
Lignans--pharmacology
Lipid Metabolism
Male
Mice, Inbred C57BL
Models, Biological
Oxidative Stress--drug effects